Related Experiment Videos
Evaluation of simvastatin antioxidant effects.
Didona Ungureanu1, Cristiana Filip, Anca Artenie
1Biochemistry Department, Gr.T. Popa University of Medicine and Pharmacy, Iaşi.
Summary
Simvastatin therapy significantly reduced total cholesterol in hypercholesterolemia patients. It also improved antioxidant enzyme activity, including superoxide dismutase (SOD) and catalase (CAT).
Area of Science:
- Biochemistry
- Pharmacology
- Cardiovascular Medicine
Background:
- Cholesterol biosynthesis is regulated by 3-Hydroxy-3-methyl-coenzyme A reductase (HMG-CoA reductase).
- Statins, like simvastatin, are widely used to manage hypercholesterolemia by inhibiting HMG-CoA reductase.
- Oxidative stress plays a role in cardiovascular disease, and antioxidant enzymes are crucial for cellular protection.
Purpose of the Study:
- To investigate the effect of simvastatin on total cholesterol levels.
- To evaluate the impact of simvastatin therapy on key enzymatic antioxidant parameters.
Main Methods:
- A study involving 25 hypercholesterolemic subjects (12 men, 12 women, aged 33-67).
- Participants received 10 mg of simvastatin daily for 8 months.
- Measurements included total cholesterol and enzymatic antioxidant levels (superoxide dismutase, glutathione peroxidase, catalase).
Main Results:
- Simvastatin treatment resulted in a statistically significant decrease in total cholesterol (p < 0.0001).
- Enzymatic antioxidant parameters, including superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT), showed improvement.
- Specific increases were observed in the CAT/SOD and GPx/SOD ratios.
Conclusions:
- Simvastatin therapy effectively lowers total cholesterol in patients with hypercholesterolemia.
- Simvastatin treatment positively influences antioxidant defense mechanisms by altering SOD, GPx, and CAT levels and ratios.